Glynis Ablon
Dermatology · Manhattan Beach, CANPI 1144292889
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (46.7%), speaking fees and travel and lodging — rather than concentrated in one kind of arrangement. Galderma Laboratories, L.p. accounts for 84.5% of it on its own, with 27 other manufacturers making up the rest. 2025 is the largest year on record at $95,238, more than ten times the $3,530 reported in 2019. Among dermatology clinicians in CA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 361 payments — averaging $417.42 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Galderma Laboratories, L.p.$127K
- AbbVie$5K
- Ipsen Innovation$5K
- Strata Skin Sciences, Inc.$4K
- Dermira, Inc.$3K
- Pfizer$2K
- plus $5K from 22 others
Across 78 payments — averaging $11,788 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Bausch Health US, LLC$495K
- Eli Lilly$187K
- VYNE Pharmaceuticals Inc.$130K
- Galderma Laboratories, L.p.$102K
- Avita Medical Americas, LLC$6K
What the payments were for
- Consulting fees$70,40347%
- Speaking & faculty fees$46,30031%
- Travel & lodging$24,52016%
- Food & beverage$9,3746%
- Education$930%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Galderma Laboratories, L.p. | 142 | $127,389 |
| AbbVie(2 entities) | 21 | $4,533 |
| Ipsen Innovation | 3 | $4,505 |
| Strata Skin Sciences, Inc. | 3 | $4,041 |
| Dermira, Inc. | 9 | $3,081 |
| Pfizer | 25 | $2,123 |
| Botanix SB Inc | 2 | $1,019 |
| Merz North America, Inc. | 11 | $921 |
| Mayne Pharma Commercial LLC | 40 | $568 |
| Almirall LLC | 10 | $328 |
| Johnson & Johnson | 12 | $312 |
| Incyte Corporation | 11 | $308 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 17 | $300 |
| Sun Pharmaceutical Industries Inc. | 12 | $282 |
| LEO Pharma Inc. | 8 | $159 |
| Medimetriks Pharmaceuticals, Inc. | 8 | $140 |
| Revance Therapeutics, Inc. | 6 | $136 |
| EPI Health, LLC | 5 | $115 |
| Novartis | 1 | $104 |
| Journey Medical Corporation | 4 | $82 |
| Arcutis Biotherapeutics, Inc. | 3 | $64 |
| Bausch Health US, LLC | 1 | $45 |
| Amgen | 1 | $33 |
| Lilly USA, LLC | 1 | $27 |
| Solta Medical, A Division Of Bausch Health US, LLC | 1 | $22 |
| Biofrontera Inc. | 1 | $22 |
| Verrica Pharmaceuticals Inc. | 1 | $20 |
| Organon | 2 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$150,690 in reported general payments places this provider in the 95th percentile of 1,875 dermatology providers in California.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| JubliaEfinaconazole | 14 | $11,392 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Ortho Dermatologics, A Division Of Bausch Health US, LLCJublia | $300 | $11,39214 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 1,875 dermatology providers in California.
Other dermatology in Manhattan Beach
- Michelle EhrlichManhattan Beach$735K
- Paul YamauchiSanta Monica$2.9M
- Jennifer SoungSanta Ana$2.8M
- Robert GreenbergLivermore$2.6M
- Neal BhatiaSan Diego$2.5M
- April ArmstrongLos Angeles$2.3M
- Jeffrey CrowleyBakersfield$2.1M
- Jashin WuCorona$2M
- Raja SivamaniSacramento$1.9M
- Tien NguyenFountain Valley$1.2M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.